{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:40:32Z","timestamp":1793392832996,"version":"4.5.0"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sudden cardiac death (SCD) represents a major cause of death in end-stage kidney disease (ESKD). The precise estimate of its incidence is difficult to establish because studies on the incidence of SCD in ESKD are often combined with those related to sudden cardiac arrest (SCA) occurring during a haemodialysis (HD) session. The aim of the European Dialysis Working Group of ERA-EDTA was to critically review the current literature examining the causes of extradialysis SCD and intradialysis SCA in ESKD patients and potential management strategies to reduce the incidence of such events. Extradialysis SCD and intradialysis SCA represent different clinical situations and should be kept distinct. Regarding the problem, numerically less relevant, of patients affected by intradialysis SCA, some modifiable risk factors have been identified, such as a low concentration of potassium and calcium in the dialysate, and some advantages linked to the presence of automated external defibrillators in dialysis units have been documented. The problem of extra-dialysis SCD is more complex. A reduced left ventricular ejection fraction associated with SCD is present only in a minority of cases occurring in HD patients. This is the proof that SCD occurring in ESKD has different characteristics compared with SCD occurring in patients with ischaemic heart disease and\/or heart failure and not affected by ESKD. Recent evidence suggests that the fatal arrhythmia in this population may be due more frequently to bradyarrhythmias than to tachyarrhythmias. This fact may partly explain why several studies could not demonstrate an advantage of implantable cardioverter defibrillators in preventing SCD in ESKD patients. Electrolyte imbalances, frequently present in HD patients, could explain part of the arrhythmic phenomena, as suggested by the relationship between SCD and timing of the HD session. However, the high incidence of SCD in patients on peritoneal dialysis suggests that other risk factors due to cardiac comorbidities and uraemia per se may contribute to sudden mortality in ESKD patients.<\/jats:p>","DOI":"10.1093\/ndt\/gfz182","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T15:21:46Z","timestamp":1566919306000},"page":"396-405","source":"Crossref","is-referenced-by-count":75,"title":["Sudden cardiac death in dialysis patients: different causes and management strategies"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-4149","authenticated-orcid":false,"given":"Simonetta","family":"Genovesi","sequence":"first","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy"},{"name":"Nephrology Unit, San Gerardo Hospital, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena University Hospital, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[{"name":"Nephrology Clinic, Dialysis and Renal Transplant Center - \u2018C.I. Parhon\u2019 University Hospital, Iasi, Romania"},{"name":"\u2018Grigore T. Popa\u2019 University of Medicine, Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin W M","family":"Vernooij","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-573X","authenticated-orcid":false,"given":"Christian","family":"Combe","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie Transplantation Dialyse Aph\u00e9r\u00e8se, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France"},{"name":"Unit\u00e9 INSERM 1026, Universit\u00e9 de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-1588","authenticated-orcid":false,"given":"Alexandru","family":"Burlacu","sequence":"additional","affiliation":[{"name":"\u2018Grigore T. Popa\u2019 University of Medicine, Iasi, Romania"},{"name":"Department of Interventional Cardiology - Cardiovascular Diseases Institute, Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Davenport","sequence":"additional","affiliation":[{"name":"UCL Centre for Nephrology, Royal Free Hospital, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Koc University School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kirmizis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Colchester General Hospital, Essex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schneditz","sequence":"additional","affiliation":[{"name":"Otto Loewi Research Center, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"van der Sande","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Basile","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy"},{"name":"Associazione Nefrologica Gabriella Sebastio, Martina Franca, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EUDIAL Working Group of ERA-EDTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"2021022208595604100_gfz182-B1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ndt\/12.5.952","article-title":"Sudden death in chronic dialysis patients","volume":"12","author":"Takeda","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCEP.113.001034","article-title":"Public health burden of sudden cardiac death in the United States","volume":"7","author":"Stecker","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2021022208595604100_gfz182-B3","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/ndt\/13.11.2745","article-title":"Intradialytic hypotension: new insights into the mechanism of vasovagal syncope","volume":"13","author":"Ligtenberg","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000500877","article-title":"The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with meta-analysis","volume":"49","author":"Kuipers","year":"2019","journal-title":"Am J Nephrol"},{"key":"2021022208595604100_gfz182-B6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1523-1755.2001.00806.x","article-title":"Cardiac arrest and sudden death in dialysis units","volume":"60","author":"Karnik","year":"2001","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2010.315","article-title":"Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics","volume":"79","author":"Pun","year":"2011","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fphys.2019.00144","article-title":"Sudden cardiac death in dialysis: arrhythmic mechanisms and the value of non-invasive electrophysiology","volume":"10","author":"Poulikakos","year":"2019","journal-title":"Front Physiol"},{"key":"2021022208595604100_gfz182-B9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.80.6.1675","article-title":"Diverse mechanisms of unexpected cardiac arrest in advanced heart failure","volume":"80","author":"Luu","year":"1989","journal-title":"Circulation"},{"key":"2021022208595604100_gfz182-B10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-8703(89)90670-4","article-title":"Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases","volume":"117","author":"Bayes de Luna","year":"1989","journal-title":"Am Heart J"},{"key":"2021022208595604100_gfz182-B11","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.288.23.3008","article-title":"Changing incidence of out-of-hospital ventricular fibrillation, 1980\u20132000","volume":"288","author":"Cobb","year":"2002","journal-title":"JAMA"},{"key":"2021022208595604100_gfz182-B12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/anec.12119","article-title":"Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator","volume":"19","author":"Wan","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2021022208595604100_gfz182-B13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.hrthm.2015.06.033","article-title":"Temporal distribution of arrhythmic events in chronic kidney disease: highest incidence in the long interdialytic period","volume":"12","author":"Wong","year":"2015","journal-title":"Heart Rhythm"},{"key":"2021022208595604100_gfz182-B14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacep.2017.08.002","article-title":"Cardiac rhythm disturbances in hemodialysis patients: early detection using an implantable loop recorder and correlation with biological and dialysis parameters","volume":"4","author":"Sacher","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2021022208595604100_gfz182-B15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.kint.2017.11.019","article-title":"Primary outcomes of the monitoring in dialysis study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle","volume":"93","author":"Roy-Chaudhury","year":"2018","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","article-title":"Characteristics of sudden death in hemodialysis patients","volume":"69","author":"Bleyer","year":"2006","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/ndt\/gfp104","article-title":"Sudden death and associated factors in a historical cohort of chronic haemodialysis patients","volume":"24","author":"Genovesi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2215\/CJN.08850811","article-title":"Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"7","author":"Jadoul","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000464347","article-title":"Sudden death in end stage renal disease: comparing hemodialysis versus peritoneal dialysis","volume":"44","author":"Genovesi","year":"2017","journal-title":"Blood Purif"},{"key":"2021022208595604100_gfz182-B20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2215\/CJN.00960112","article-title":"Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort","volume":"7","author":"Torlen","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.110.151167","article-title":"Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis","volume":"56","author":"Wang","year":"2010","journal-title":"Hypertension"},{"key":"2021022208595604100_gfz182-B22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000489963","article-title":"Obstructive sleep apnea increases sudden cardiac death in incident hemodialysis patients","volume":"48","author":"Kerns","year":"2018","journal-title":"Am J Nephrol"},{"key":"2021022208595604100_gfz182-B23","doi-asserted-by":"crossref","first-page":"e004961","DOI":"10.1161\/JAHA.116.004961","article-title":"Severe aortic stenosis in dialysis patients","volume":"6","author":"Kawase","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2021022208595604100_gfz182-B24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.ki.5002749","article-title":"Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers","volume":"73","author":"Davis","year":"2008","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1681\/ASN.2018090911","article-title":"Outcomes for hemodialysis patients given cardiopulmonary resuscitation for cardiac arrest at outpatient dialysis clinics","volume":"30","author":"Pun","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"4 Suppl 3","key":"2021022208595604100_gfz182-B26","first-page":"S18","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.CIR.0000028148.62305.69","article-title":"Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation","volume":"106","author":"Capucci","year":"2002","journal-title":"Circulation"},{"key":"2021022208595604100_gfz182-B28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.2019.1696","article-title":"In-hospital cardiac arrest: a review","volume":"321","author":"Andersen","year":"2019","journal-title":"JAMA"},{"key":"2021022208595604100_gfz182-B29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2215\/CJN.10000912","article-title":"Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients","volume":"8","author":"Pun","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B30","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1523-1755.2000.00062.x","article-title":"QTc dispersion increases during hemodialysis with low-calcium dialysate","volume":"57","author":"Nappi","year":"2000","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B31","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00004872-200310000-00020","article-title":"Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis","volume":"21","author":"Genovesi","year":"2003","journal-title":"J Hypertens"},{"key":"2021022208595604100_gfz182-B32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/europace\/eun028","article-title":"Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients","volume":"10","author":"Genovesi","year":"2008","journal-title":"Europace"},{"key":"2021022208595604100_gfz182-B33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfu376","article-title":"Ranking of factors determining potassium mass balance in bicarbonate haemodialysis","volume":"30","author":"Basile","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","article-title":"Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"69","author":"Karaboyas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1542-4758.2006.01170.x","article-title":"Composition and clinical use of hemodialysates","volume":"10","author":"Sam","year":"2006","journal-title":"Hemodial Int"},{"key":"2021022208595604100_gfz182-B36","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.CIR.83.6.1888","article-title":"QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest","volume":"83","author":"Algra","year":"1991","journal-title":"Circulation"},{"key":"2021022208595604100_gfz182-B37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archinte.164.9.943","article-title":"Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies","volume":"164","author":"Montanez","year":"2004","journal-title":"Arch Intern Med"},{"key":"2021022208595604100_gfz182-B38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/EDE.0b013e318225768b","article-title":"Electrocardiographic QT interval and mortality: a meta-analysis","volume":"22","author":"Zhang","year":"2011","journal-title":"Epidemiology"},{"key":"2021022208595604100_gfz182-B39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/europace\/eus412","article-title":"A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval","volume":"15","author":"Genovesi","year":"2013","journal-title":"Europace"},{"key":"2021022208595604100_gfz182-B40","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfm765","article-title":"Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis","volume":"23","author":"Severi","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ki.1996.356","article-title":"Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhytmias","volume":"50","author":"Redaelli","year":"1996","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B42","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ndt\/gfm730","article-title":"Patients with complex arrhytmias during and after haemodialysis suffer from different regimens of potassium removal","volume":"23","author":"Santoro","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B43","first-page":"305","article-title":"Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Gruppo Emodialisi e Patologie Cardiovasculari","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"2021022208595604100_gfz182-B44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0140-6736(92)90008-Q","article-title":"Ventricular arrhythmias and four-year mortality in haemodialysis patients","volume":"339","author":"Sforzini","year":"1992","journal-title":"Lancet"},{"key":"2021022208595604100_gfz182-B45","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ndt\/gfx241","article-title":"Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients","volume":"33","author":"Brunelli","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000360094","article-title":"Potassium-binding resins: associations with serum chemistries and interdialytic weight gain in hemodialysis patients","volume":"39","author":"Jadoul","year":"2014","journal-title":"Am J Nephrol"},{"key":"2021022208595604100_gfz182-B47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"2021022208595604100_gfz182-B48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"key":"2021022208595604100_gfz182-B49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.ajkd.2011.08.033","article-title":"Effect of dialysate calcium concentration on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial","volume":"59","author":"Basile","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/sdi.12716","article-title":"Dialysate bicarbonate concentration: too much of a good thing?","volume":"31","author":"Basile","year":"2018","journal-title":"Semin Dial"},{"key":"2021022208595604100_gfz182-B51","first-page":"190","article-title":"Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis","volume":"47","author":"van Kuijk","year":"1997","journal-title":"Clin Nephrol"},{"key":"2021022208595604100_gfz182-B52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MNH.0b013e328365b34c","article-title":"Improving outcomes by changing hemodialysis practice patterns","volume":"22","author":"Fissell","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2021022208595604100_gfz182-B53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ndt\/gfh661","article-title":"The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients","volume":"20","author":"Heguil\u00e9n","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5301\/jn.5000036","article-title":"Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects","volume":"25","author":"Di Iorio","year":"2012","journal-title":"J Nephrol"},{"key":"2021022208595604100_gfz182-B55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ki.2013.327","article-title":"Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis","volume":"85","author":"Sakaguchi","year":"2014","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B56","doi-asserted-by":"crossref","first-page":"e0143104","DOI":"10.1371\/journal.pone.0143104","article-title":"Serum magnesium and sudden death in european hemodialysis patients","volume":"10","author":"de Roij van Zuijdewijn","year":"2015","journal-title":"PLoS One"},{"key":"2021022208595604100_gfz182-B57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.ackd.2018.02.010","article-title":"Magnesium and cardiovascular disease","volume":"25","author":"Tangvoraphonkchai","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"2021022208595604100_gfz182-B58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000496083","article-title":"Effects of beta-blockers on cardiovascular events and mortality in dialysis patients: a systematic review and meta-analysis","volume":"48","author":"Jin","year":"2019","journal-title":"Blood Purif"},{"key":"2021022208595604100_gfz182-B59","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000232593","article-title":"Beta-blocker prescription and outcomes in hemodialysis patients from the Japan Dialysis Outcomes and Practice Patterns Study","volume":"113","author":"Nakao","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"2021022208595604100_gfz182-B60","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","article-title":"Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study","volume":"62","author":"Foley","year":"2002","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B61","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2021022208595604100_gfz182-B62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1053\/j.ajkd.2011.06.024","article-title":"\u03b2-blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study","volume":"58","author":"Tangri","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B63","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2215\/CJN.07831109","article-title":"Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis","volume":"5","author":"Tai","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B64","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ndt\/gfs590","article-title":"Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial","volume":"28","author":"Iseki","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B65","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B66","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2021022208595604100_gfz182-B67","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","article-title":"ACE inhibitors and survival of hemodialysis patients","volume":"40","author":"Efrati","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0735-1097(03)00572-2","article-title":"Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction","volume":"42","author":"Berger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2021022208595604100_gfz182-B69","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"2021022208595604100_gfz182-B70","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000168604","article-title":"Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease","volume":"13","author":"Singhal","year":"1993","journal-title":"Am J Nephrol"},{"key":"2021022208595604100_gfz182-B71","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.ajkd.2006.01.014","article-title":"A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients","volume":"47","author":"Kaisar","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B72","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2215\/CJN.02360706","article-title":"Predictors of survival after cardiac arrest in outpatient hemodialysis clinics","volume":"2","author":"Pun","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B74","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1046\/j.1523-1755.2002.00355.x","article-title":"Calcium channel blocker use and mortality among patients with end-stage renal disease","volume":"61","author":"Kestenbaum","year":"2002","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B75","first-page":"CD006254","article-title":"Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients","volume":"12","author":"Ballinger","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2021022208595604100_gfz182-B76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B77","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2016.19456","article-title":"Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"2021022208595604100_gfz182-B78","first-page":"CD008093","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"12","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021022208595604100_gfz182-B79","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1681\/ASN.2009101047","article-title":"Digoxin associates with mortality in ESRD","volume":"21","author":"Chan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B80","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022208595604100_gfz182-B81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/gfu015","article-title":"Drug adherence in chronic kidney diseases and dialysis","volume":"30","author":"Burnier","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B82","first-page":"1601","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"2021022208595604100_gfz182-B83","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"2021022208595604100_gfz182-B84","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a de\ufb01brillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2021022208595604100_gfz182-B85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2021022208595604100_gfz182-B86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10840-010-9484-6","article-title":"Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients","volume":"28","author":"Khan","year":"2010","journal-title":"J Interv Card Electrophysiol"},{"key":"2021022208595604100_gfz182-B87","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCEP.114.001455","article-title":"Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease","volume":"7","author":"Paul","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2021022208595604100_gfz182-B88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1540-8159.2007.00678.x","article-title":"Impact of renal function on survival in patients with implantable cardioverter-defibrillators","volume":"30","author":"Turakhia","year":"2007","journal-title":"Pacing Clin Electro physiol"},{"key":"2021022208595604100_gfz182-B89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000319461","article-title":"Implantable defibrillators improve survival in end-stage renal disease: results from a multi-center registry","volume":"32","author":"Hiremath","year":"2010","journal-title":"Am J Nephrol"},{"key":"2021022208595604100_gfz182-B90","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2021022208595604100_gfz182-B91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.03.178","article-title":"Mortality, sudden death and indication for cardioverter defibrillator implantation in a dialysis population","volume":"186","author":"Genovesi","year":"2015","journal-title":"Int J Cardiol"},{"key":"2021022208595604100_gfz182-B92","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"2021022208595604100_gfz182-B93","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2014.01.085","article-title":"Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry","volume":"64","author":"Hsu","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2021022208595604100_gfz182-B94","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0085-2538(15)50904-6","article-title":"Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators","volume":"68","author":"Herzog","year":"2005","journal-title":"Kidney Int"},{"key":"2021022208595604100_gfz182-B95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B96","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euv053","article-title":"Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis","volume":"17","author":"Polyzos","year":"2015","journal-title":"Europace"},{"key":"2021022208595604100_gfz182-B97","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":"Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making\u2013a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"2021022208595604100_gfz182-B98","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/j.ajkd.2007.02.272","article-title":"Increased complication rates of cardiac rhythm management devices in ESRD patients","volume":"49","author":"Dasgupta","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B99","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1540-8167.2011.02066.x","article-title":"End-stage renal disease predicts complications in pacemaker and ICD implants","volume":"22","author":"Tompkins","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021022208595604100_gfz182-B100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ajkd.2015.01.028","article-title":"Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections","volume":"66","author":"Dhamija","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2021022208595604100_gfz182-B101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/europace\/euy110","article-title":"European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)","volume":"21","author":"Boriani","year":"2019","journal-title":"Europace"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/3\/396\/36327646\/gfz182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/3\/396\/36327646\/gfz182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T04:16:17Z","timestamp":1613967377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/36\/3\/396\/5571895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,20]]},"published-print":{"date-parts":[[2021,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz182","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2019,9,20]]}}}